|
CACYBP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.454800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.838000E-03 |
| Normal-vs-Stage2 |
4.949800E-01 |
| Normal-vs-Stage3 |
4.694100E-02 |
| Normal-vs-Stage4 |
5.107800E-02 |
| Stage1-vs-Stage2 |
4.646000E-01 |
| Stage1-vs-Stage3 |
8.158700E-03 |
| Stage1-vs-Stage4 |
2.613600E-02 |
| Stage2-vs-Stage3 |
3.230300E-02 |
| Stage2-vs-Stage4 |
3.940400E-02 |
| Stage3-vs-Stage4 |
2.633600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.546400E-01 |
| Normal-vs-AfricanAmerican |
5.073600E-01 |
| Normal-vs-Asian |
2.867000E-01 |
| Caucasian-vs-AfricanAmerican |
6.985000E-01 |
| Caucasian-vs-Asian |
1.872240E-01 |
| AfricanAmerican-vs-Asian |
8.697900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.638620E-01 |
| Normal-vs-Female |
1.029630E-01 |
| Male-vs-Female |
1.002080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.435800E-01 |
| Normal-vs-Extreme_Weight |
3.227400E-01 |
| Normal-vs-Obese |
5.758400E-01 |
| Normal-vs-Extreme_Obese |
3.534400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.921600E-01 |
| Normal_Weight-vs-Obese |
6.783000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.347600E-01 |
| Extreme_Weight-vs-Obese |
8.933200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.391400E-01 |
| Obese-vs-Extreme_Obese |
6.771000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.916300E-02 |
| Normal-vs-Age(41-60Yrs) |
8.310800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.896790E-01 |
| Normal-vs-Age(81-100Yrs) |
6.664900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.707800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.042100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.161400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.156400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.540000E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.352200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.395700E-02 |
| Normal-VS-Type2 PRCC |
4.808600E-01 |
| Normal-VS-KIRP CIMP |
4.436900E-03 |
| Normal-VS-Unclassified PRCC |
7.217200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.388400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.096300E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
4.618600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.980900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.295600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.785300E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.162200E-01 |
| Normal-vs-N1 |
1.998360E-03 |
| Normal-vs-N2 |
3.998000E-01 |
| N0-vs-N1 |
1.015340E-03 |
| N0-vs-N2 |
1.450770E-01 |
| N1-vs-N2 |
4.081400E-01 |
|
|
